ATEA PHARMACEUTICALS INC shareholders Q3 2023

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.

ATEA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
PRELUDE CAPITAL MANAGEMENT, LLC 64,208$192,6240.01%
BANQUE PICTET & CIE SA 345,077$1,035,2310.01%
ACADIAN ASSET MANAGEMENT LLC 987,916$2,9610.01%
Vontobel Holding Ltd. 600,461$1,801,3830.01%
CSS LLC/IL 49,300$147,9000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 553,377$1,660,1310.01%
Pinnacle Wealth Planning Services, Inc. 16,185$48,5550.01%
Renaissance Technologies 1,354,541$4,0640.01%
ALGERT GLOBAL LLC 50,510$1520.01%
CSS LLC/IL 23,100$69,3000.01%
FEDERATED HERMES, INC. 608,786$1,826,3580.01%
Cubist Systematic Strategies, LLC 139,073$417,2190.00%
NEW YORK LIFE INVESTMENT MANAGEMENT LLC 106,281$318,8430.00%
FMR LLC 6,452,550$19,357,6510.00%
China Universal Asset Management Co., Ltd. 2,139$60.00%
HRT FINANCIAL LP 71,136$2130.00%
CSS LLC/IL 11,016$33,0480.00%
ALPS ADVISORS INC 61,573$184,7190.00%
TWO SIGMA ADVISERS, LP 205,900$617,7000.00%
Ameritas Investment Partners, Inc. 5,064$15,1920.00%
External links

This page lists ATEA PHARMACEUTICALS INC's shareholders in Q3 2023. To view ATEA PHARMACEUTICALS INC's shareholder history, click here.